作者
Thomas J Kiernan, Nicholas J Ruggiero 2nd, Juan M Bernal, Creighton W Don, Christian Witzke, Gareth D Kiernan, Roberto J Cubeddu, Bryan P Yan
发表日期
2009/7/1
来源
Cardiovascular & hematological agents in medicinal chemistry
卷号
7
期号
3
页码范围
181-192
简介
The no-reflow phenomenon is a poorly understood complication of percutaneous coronary intervention in which diminished blood flow to distal microvascular beds persists despite the successful treatment of the occlusive lesion from the epicardial coronary artery or arteries. In this contemporary review we endeavour to discuss the pathophysiology of coronary no-reflow, understand the predictors and describe current pharmacological and mechanical strategies to prevent and treat coronary no-reflow.
引用总数
20102011201220132014201520161434644
学术搜索中的文章
TJ Kiernan, NJ Ruggiero 2nd, JM Bernal, CW Don… - Cardiovascular & hematological agents in medicinal …, 2009